DE102013017917A1 - L-Thyrogal - Google Patents

L-Thyrogal Download PDF

Info

Publication number
DE102013017917A1
DE102013017917A1 DE201310017917 DE102013017917A DE102013017917A1 DE 102013017917 A1 DE102013017917 A1 DE 102013017917A1 DE 201310017917 DE201310017917 DE 201310017917 DE 102013017917 A DE102013017917 A DE 102013017917A DE 102013017917 A1 DE102013017917 A1 DE 102013017917A1
Authority
DE
Germany
Prior art keywords
thyrogal
liquid
gets
diseased
thyroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE201310017917
Other languages
English (en)
Inventor
wird später genannt werden Erfinder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE201310017917 priority Critical patent/DE102013017917A1/de
Publication of DE102013017917A1 publication Critical patent/DE102013017917A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Zu dieser Anmeldung wurden keine Patentansprüche eingereicht.

Description

  • Flüssiges Schilddrüsenheilmittel (f. d. Pipette)
  • Wirkung:
  • Ein Tropfen oder 1/2 Pipette voll, und eine erkrankte Schilddrüse arbeitet wieder, man wird ruhig durch das Mittel, bekommt ganz leicht Hunger und der kranke Stoffwechsel arbeitet wieder mit Jodid.

    Flüssig zur feinen Freisetzung!
  • Zusammensetzung:
    • Flüssiges Thyroxen, 1–10% flüssiges Ethanol, und flüssiges Fuselöl.

Claims (1)

  1. Zu dieser Anmeldung wurden keine Patentansprüche eingereicht.
DE201310017917 2013-10-26 2013-10-26 L-Thyrogal Withdrawn DE102013017917A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE201310017917 DE102013017917A1 (de) 2013-10-26 2013-10-26 L-Thyrogal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE201310017917 DE102013017917A1 (de) 2013-10-26 2013-10-26 L-Thyrogal

Publications (1)

Publication Number Publication Date
DE102013017917A1 true DE102013017917A1 (de) 2015-04-30

Family

ID=52811366

Family Applications (1)

Application Number Title Priority Date Filing Date
DE201310017917 Withdrawn DE102013017917A1 (de) 2013-10-26 2013-10-26 L-Thyrogal

Country Status (1)

Country Link
DE (1) DE102013017917A1 (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291021B1 (de) * 2001-07-02 2005-12-14 Altergon S.A. Pharmazeutische Formulierungen von Thyroidhormonen
WO2007077252A1 (en) * 2006-01-06 2007-07-12 Intervet International B.V. Concentrated liquid thyroid hormone composition
WO2013072304A1 (en) * 2011-11-14 2013-05-23 Altergon S.A. Single-dose pharmaceutical preparation of thyroid hormones t3 and/or t4

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291021B1 (de) * 2001-07-02 2005-12-14 Altergon S.A. Pharmazeutische Formulierungen von Thyroidhormonen
WO2007077252A1 (en) * 2006-01-06 2007-07-12 Intervet International B.V. Concentrated liquid thyroid hormone composition
WO2013072304A1 (en) * 2011-11-14 2013-05-23 Altergon S.A. Single-dose pharmaceutical preparation of thyroid hormones t3 and/or t4

Similar Documents

Publication Publication Date Title
CL2015002221A1 (es) Método para convertir insectos o gusanos en flujos de nutrientes y las composiciones obtenidas de ese modo.
BR112016030787A2 (pt) entidade química, composição farmacêutica e seu uso
EP4220291A3 (de) Gegenelektrode für elektrochrome vorrichtungen
WO2016036707A3 (en) Counter electrode for electrochromic devices
FR3000670B1 (fr) Composition cosmetique apaisante a base d'acide salicylique.
BR112017024752A2 (pt) material eletrolítico básico estável e material solvente contendo o mesmo.
EP3057961A4 (de) Photoinitiator und lichtempfindliche zusammensetzung damit
BR112017022815A2 (pt) material de eletrólito estável e material de solvente contendo o mesmo.
DE112014003462A5 (de) Transparente Sonnenschutzmittelzusammensetzungen und deren Verwendung
BR112014030591A2 (pt) "método para a preparação de uma maionese livre de edta, maionese livre de edta e uso do suco reduzido de uva como como substituto de edta"
PH12016501053A1 (en) Film compositions for oral use
FR3029915B1 (fr) Tripeptides, compositions les comprenant et utilisations notamment cosmetiques
Shotton et al. Beyond the asterisk: Understanding Native American college students.
BR112015006692A2 (pt) formulação de nanodispersão, método para administrar uma formulação de nanodispersão líquida de taxina livre de etanol em um indivíduo, e, kit.
DE102013017917A1 (de) L-Thyrogal
BR112015022975A2 (pt) partículas de resinato de fenilefrina
Konzernrecht Friedrich Hoffmann
BR112014029900A2 (pt) método para controlar as substâncias presentes em um líquido e suas aplicações.
Batou “The Makhzen Institution in Morocco’s History” by Mohammed Jadour
de Schipper The Beginning of the Year in the Anglo Saxon Chronicle
井本翔 et al. Theoretical studies on ultrafast dynamics of liquid water using linear and nonlinear spectroscopy
Hamad The Governance Crisis in Sudan: Crisis of Hegemony or Hegemony of Crisis?
Mahmoud The Islamist Solution in Jordan
বৰুৱা et al. পটাচাৰা
Arslan Nonlinear Differential Equations with Biological Applications

Legal Events

Date Code Title Description
R123 Application deemed withdrawn due to non-payment of filing fee
R409 Internal rectification of the legal status completed
R409 Internal rectification of the legal status completed
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee